Evidence map›Paper›PMID 25925491›Full record

Trial reportHormone research in paediatrics2015

Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a.

Hannah Landreth, Beth A Malow, Ashley H Shoemaker

4 registry-linked trialsOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Hormone research in paediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02411461 completednot on this map

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

TypeobservationalSponsorVanderbilt University Medical CenterRan2014 to 2017Enrolled39ConditionsPseudohypoparathyroidism, Albright Hereditary Osteodystrophy
NCT02463409 phase2completednot on this map

Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a

TypeinterventionalSponsorVanderbilt University Medical CenterRan2015 to 2016Enrolled6ConditionsPseudohypoparathyroidism Type 1a, Albright Hereditary OsteodystrophyArmsTheophylline
NCT03029429 phase2active not recruitingnot on this mapstarted 2018, after this paper: background citation

Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism

TypeinterventionalSponsorVanderbilt University Medical CenterRan2018 to 2026Enrolled29ConditionsPseudohypoparathyroidism, Albright Hereditary OsteodystrophyArmsTheophylline, Placebos
NCT04551170 phase2active not recruitingnot on this mapstarted 2020, after this paper: background citation

Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism

TypeinterventionalSponsorVanderbilt University Medical CenterRan2020 to 2026Enrolled34ConditionsPseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1aArmsTheophylline, Placebo
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Management of pseudohypoparathyroidism.Current opinion in pediatrics · 2019
    Review
  5. Pseudohypoparathyroidism.Endocrinology and metabolism clinics of North America · 2018
    Review
  6. Review
  7. Article
  8. Nonclassic features of pseudohypoparathyroidism type 1A.Current opinion in endocrinology, diabetes, and obesity · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hannah LandrethUniversity of Oklahoma School of Medicine, Norman, Okla., USA.
Beth A Malow
Ashley H Shoemaker
University of Oklahoma · USVanderbilt University · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Vanderbilt Student Research Training ProgramT35DK007383 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI William Heerman · 1986 to 2026
$4.1M
The Vanderbilt Institute for Clinical and Translational Research (VICTR) KL2KL2RR024977 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$3.0M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)KL2TR000446 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$2.8M
Early Onset Obesity and Cognitive Impairment in PseudohypoparathyroidismK23DK101689 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHOEMAKER, ASHLEY HALL · 2014 to 2018
$778k
HEMATOLOGY TRAINING GRANTT32DK007373 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BANK, ARTHUR · 1986 to 2004
$637k
NCATS NIH HHS KL2 TR000446NCATS NIH HHS KL2TR000446NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1TR00445NCRR NIH HHS KL2 RR024977NIDDK NIH HHS DK007373NIDDK NIH HHS DK20593NIDDK NIH HHS K23 DK101689NIDDK NIH HHS K23DK101689NIDDK NIH HHS P30 DK020593NIDDK NIH HHS T32 DK007373NIDDK NIH HHS T35 DK007383
6 · The paper itself

Abstract

BACKGROUND/

aimsPseudohypoparathyroidism type 1a (PHP1a) is a rare genetic disorder. This study aimed to determine the prevalence of sleep apnea in children with PHP1a.

methodsNineteen patients with PHP1a between the age of 2 and 21 years were enrolled prospectively using online advertisements. Parents completed a medical history and surveys to assess sleep behavior. Polysomnography records were obtained when available. In addition, 18 subjects were identified in a retrospective chart review of de-identified medical records with 2.3 million patient charts.

resultsParents reported sleep disturbance (94%) and daytime somnolence (81%) in their children with PHP1a. In the retrospective chart review, 39% had a history of sleep apnea versus 8.8% of a similarly obese control group. In the combined analysis (n = 31), 52% had a history of snoring and 45% had a diagnosis of sleep apnea. Patients were obese with a mean BMI z-score of 2.20 ± 0.59. Patients with sleep apnea were significantly younger than those without a diagnosis (8.1 ± 5.4 vs. 12.8 ± 5.0 years, p = 0.02).

conclusionsChildren with PHP1a have a 4.4-fold greater relative risk of sleep apnea than similarly obese children. Screening for sleep apnea in this population may be warranted to prevent adverse health outcomes.

Indexed as

AdolescentChildFemaleHumansMaleObesityPolysomnographyPrevalencePseudohypoparathyroidismRisk FactorsSleep Apnea Syndromes

Identifiers

PMID25925491
PMCPMC4540680
OpenAlexW1990568334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.